Transplanting Hepatitis C Lungs Into Negative Lung Recipients

Summary

This study is being conducted to determine safety and effectiveness of transplanting lungs from Hepatitis C-positive donors into Hepatitis C-negative patients on the lung transplant waitlist, who will then be treated with appropriate direct-acting antiviral (DAA) after transplantation.

Timeline

Start

2018-12-12

Primary completion

2021-12-31

Completion

2022-12-31

Drugs

Indications